124 related articles for article (PubMed ID: 34673587)
1. Expression of VEGF-A, HER2/neu, and
Singh P; Jain SL; Sakhuja P; Agarwal A
Indian J Pathol Microbiol; 2021; 64(4):687-692. PubMed ID: 34673587
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological and prognostic significance of VEGF, PDGF-B, and HER2/neu expression in gallbladder cancer.
Shukla P; Mishra K; Shukla R; Vishwakarma R; Kumari N; Krishnani N; Behari A; Kapoor VK
J Cancer Res Ther; 2024 Jan; 20(1):349-357. PubMed ID: 38554345
[TBL] [Abstract][Full Text] [Related]
3. Expression of Human Epidermal Growth Factor Receptor (Her 2/neu) and Proliferative Marker Ki-67: Association with Clinicopathological Parameters in Gallbladder Carcinoma.
Pujani M; Makker I; Makker A; Jetley S; Goel MM; Jetley S
Asian Pac J Cancer Prev; 2016; 17(8):3903-9. PubMed ID: 27644637
[TBL] [Abstract][Full Text] [Related]
4. Expression of ER, PR, and HER-2 Neu and correlation with tumor markers in gall bladder carcinoma.
Mani R; Gupta A; Gupta S; Goyal B; Mishra R; Tandon A; Sharma O; Rohilla KK; Kishore S; Dhar P
J Cancer Res Ther; 2023; 19(5):1279-1287. PubMed ID: 37787296
[TBL] [Abstract][Full Text] [Related]
5. HER-2/neu over expression in gall bladder adenocarcinoma: A quest for potential therapeutic target.
Jain P; Goyal S; Chauhan G; Majumdar K; Ali S; Sakhuja P; Agarwal AK
Indian J Pathol Microbiol; 2020; 63(2):214-220. PubMed ID: 32317518
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of HER2 status in bladder transitional cell carcinoma revealed by both IHC and BDISH techniques.
Nedjadi T; Al-Maghrabi J; Assidi M; Dallol A; Al-Kattabi H; Chaudhary A; Al-Sayyad A; Al-Ammari A; Abuzenadah A; Buhmeida A; Al-Qahtani M
BMC Cancer; 2016 Aug; 16():653. PubMed ID: 27539085
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical expression of vascular endothelial growth factor A in advanced gallbladder carcinoma.
Letelier P; Garcia P; Leal P; Ili C; Buchegger K; Riquelme I; Sandoval A; Tapia O; Roa JC
Appl Immunohistochem Mol Morphol; 2014 Aug; 22(7):530-6. PubMed ID: 24185122
[TBL] [Abstract][Full Text] [Related]
8. Prognostic implications of estrogen receptor 1 and vascular endothelial growth factor A expression in primary gallbladder carcinoma.
Zhang LQ; Xu XS; Wan Y; Song SD; Wang RT; Chen W; Wang ZX; Chang HL; Wei JC; Dong YF; Liu C
World J Gastroenterol; 2015 Jan; 21(4):1243-50. PubMed ID: 25632198
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic Value of Circulating Free DNA Integrity and Global Methylation Status in Gall Bladder Carcinoma.
Kumari S; Husain N; Agarwal A; Neyaz A; Gupta S; Chaturvedi A; Lohani M; Sonkar AA
Pathol Oncol Res; 2019 Jul; 25(3):925-936. PubMed ID: 29376201
[TBL] [Abstract][Full Text] [Related]
10. p53, carcinoembryonic antigen and carbohydrate antigen 19.9 expression in gall bladder cancer, precursor epithelial lesions and xanthogranulomatous cholecystitis.
Agrawal V; Goel A; Krishnani N; Pandey R; Agrawal S; Kapoor VK
J Postgrad Med; 2010; 56(4):262-6. PubMed ID: 20935395
[TBL] [Abstract][Full Text] [Related]
11. Low Expression of MicroRNA335-5p Is Associated with Malignant Behavior of Gallbladder Cancer: A Clinicopathological Study.
Fatima N; Srivastava AN; Nigam J; Raza ST; Rizvi S; Siddiqui Z; Kumar V
Asian Pac J Cancer Prev; 2019 Jun; 20(6):1895-1900. PubMed ID: 31244315
[TBL] [Abstract][Full Text] [Related]
12. HER2 gene (ERBB2) amplification is a low-frequency driver with potential predictive value in gallbladder carcinoma.
Albrecht T; Rausch M; Roessler S; Geissler V; Albrecht M; Halske C; Seifert C; Renner M; Singer S; Mehrabi A; Vogel MN; Pathil-Warth A; Busch E; Köhler B; Rupp C; Weiss KH; Springfeld C; Röcken C; Schirmacher P; Goeppert B
Virchows Arch; 2020 Jun; 476(6):871-880. PubMed ID: 31838585
[TBL] [Abstract][Full Text] [Related]
13. Prognostic relevance of human telomerase reverse transcriptase (hTERT) expression in patients with gall bladder disease and carcinoma.
Deblakshmi RK; Deka M; Saikia AK; Sharma BK; Singh N; Das NN; Bose S
Asian Pac J Cancer Prev; 2015; 16(7):2923-8. PubMed ID: 25854384
[TBL] [Abstract][Full Text] [Related]
14. A significant subgroup of resectable gallbladder cancer patients has an HER2 positive status.
Yoshida H; Shimada K; Kosuge T; Hiraoka N
Virchows Arch; 2016 Apr; 468(4):431-9. PubMed ID: 26758058
[TBL] [Abstract][Full Text] [Related]
15. Study of morphology with assessment of expression of proliferation marker Ki67 antigen and P53 protein in lesions of gall bladder.
Ramesh O; Gupta M; Kaushik S; Acharya S; Thakur B; Bhardwaj A
Indian J Pathol Microbiol; 2024 Apr; 67(2):367-373. PubMed ID: 38391184
[TBL] [Abstract][Full Text] [Related]
16. HER2/neu expression correlates with vascular endothelial growth factor-C and lymphangiogenesis in lymph node-positive breast cancer.
Schoppmann SF; Tamandl D; Roberts L; Jomrich G; Schoppmann A; Zwrtek R; Dubsky P; Gnant M; Jakesz R; Birner P
Ann Oncol; 2010 May; 21(5):955-60. PubMed ID: 19940005
[TBL] [Abstract][Full Text] [Related]
17. Expression of vascular endothelial growth factor and HER2/neu in stage II colon cancer and correlation with survival.
Ochs AM; Wong L; Kakani V; Neerukonda S; Gorske J; Rao A; Riggs M; Ward H; Keville L
Clin Colorectal Cancer; 2004 Nov; 4(4):262-7. PubMed ID: 15555209
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological correlation of cancer stem cell markers Oct-4 and CD133 expression as prognostic factor in malignant lesions of gallbladder: An immunohistochemical study.
Fatima N; Srivastava AN; Nigam J; Tandon N; Ahmad R; Kumar V
Indian J Pathol Microbiol; 2019; 62(3):384-390. PubMed ID: 31361225
[TBL] [Abstract][Full Text] [Related]
19. [Expression of Her2/neu in locally advanced bladder cancer: implication for a molecular targeted therapy].
Wülfing C; von Struensee D; Bierer S; Bögemann M; Hertle L; Eltze E
Aktuelle Urol; 2005 Sep; 36(5):423-9. PubMed ID: 16163605
[TBL] [Abstract][Full Text] [Related]
20. Microarray based gene expression profiling of advanced gall bladder cancer.
Kumar A; Gupta R; Mathur N; Iyer VK; Thulkar S; Prasad CP; Das P; Rani L; Maqbool M; Shukla NK; Pal S; Sundar D; Sharma A
Exp Oncol; 2020 Dec; 42(4):277-284. PubMed ID: 33355862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
